Back to Alzheimers Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT05643326

NCT05643326
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

For patients:

  • You have been diagnosed with mild Alzheimer's disease, based on a standard rating scale score between 0.5 and 1 (known as CDR)

For caregivers:

  • You are 18 years old or older
  • You are willing to attend training on how to use the treatment device being studied
  • You score above 26 out of 30 on a standard memory and thinking test (confirm with trial site)

Who may not be able to join:

For patients:

  • You have a condition affecting the blood vessels in the brain
  • You have previously had a stroke
  • You have a condition called hydrocephalus (excess fluid on the brain)
  • A brain scan (MRI) has shown a growth or mass inside your skull
  • You have a history of a brain injury or another condition affecting the nervous system
  • You have a serious medical illness other than Alzheimer's disease
  • You have a history of seizures (epilepsy or fits)
  • You are pregnant
  • You have any metal implants in your head (dental fillings are acceptable)
  • You have an electronic implant inside your body, such as a pacemaker or a medical pump
  • You are under 18 years old

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Registry
clinicaltrials_gov
Start date
10 December 2022
Est. completion
15 October 2024

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Safety of transcranial alternating current stimulation delivered at home; Tolerability of transcranial alternating current stimulation delivered at home; Changes in Clinical Dementia Rating scale (CDR) sum of boxes; Changes in Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog)13; Changes in Face-Name Associative Memory Test (FNAT) scores; Changes in Alzheimer's Disease Assessment Scale Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov